Skip to main content
SpringerLink
Log in

Enalapril in Essential Hypertension

  • Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril
  • Published:
Drugs Aims and scope Submit manuscript

Summary

It is now well recognised that the renin-angiotensin system plays a key role in the control of blood pressure not only through circulating angiotensin II but through its interaction with the autonomie and central nervous systems. Angiotensin-converting enzyme (ACE) inhibitors have proved to be effective in lowering blood pressure in different types of hypertension. This study evaluates the antihypertensive effects of enalapril, a new, potent, long acting ACE inhibitor.

50 patients with uncomplicated essential hypertension were included in 4 groups. Group I was used to compare the effects of enalapril and propranolol on blood pressure, renal function, plasma renin activity, aldosterone excretion and plasma lipids in 24 patients after 23 weeks. Group II was used to evaluate long term effects (48 weeks) of these drugs in 13 patients. Group III included 32 patients that received enalapril as monotherapy for 6 to 12 weeks. Group IV was studied to estimate the antihypertensive effect of low doses of hydrochlorothiazide in 18 patients receiving enalapril.

The effect on mean blood pressure was similar with enalapril and propranolol (enalapril 117 versus 103mm Hg and propranolol 115 versus 104mm H g); however, the glomerular filtration rate decreased with propranolol (105 versus 87 ml/min; p <0.05) and was unaltered with enalapril (102 versus 98 ml/min). Triglycerides rose with propranolol (179 versus 231 mg/dl; p <0.05) and did not change with enalapril (157 versus 121 mg/ dl). In the long term, antihypertensive effects were similar and no significant side effects were observed. In 14/32 patients blood pressure became normal with enalapril alone. Low doses of hydrochlorothiazide (12.5 to 25mg) decreased mean blood pressure by 10mm Hg when added to enalapril.

The antihypertensive effect of enalapril was similar to that of propranolol; however, the lowering effect on glomerular filtration rate of propranolol did not occur with enalapril. A slight rise in triglycerides occurred only with propranolol. No significant side effects were observed with either propranolol or enalapril. Used as monotherapy, enalapril normalised blood pressure in 44% of cases. Addition of low doses of hydrochlorothiazide significantly increased the antihypertensive effect of enalapril.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Antonaccio, M.J. and Kerwin, L.: Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Hypertension 3 (Suppl. 1): 54–62 (1981).

    CAS  Google Scholar 

  • Bauer, J. and Gaddy, P.: Long-term enalapril/hydrochlorothiazide therapy markedly improves impaired renal function in patients with essential hypertension. Abstracts of the IXth International Congress of Nephrology, Los Angeles, California, USA pp.201A (1984).

  • Berglünd, G. and Anderson, O.: Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. Lancet 1: 744–747 (1981).

    Article  PubMed  Google Scholar 

  • Biollaz, J.; Brunner, H.R.; Waeber, B. and Gavras, H.: Anti-hypertensive therapy with MK-421: Angiotensin II renin relationship to evaluate efficacy of converting enzyme blockade. Journal of Cardiovascular Pharmacology 4: 966–972 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Brunner, D.B.; Desponds, G.; Biollaz, J.; Keller, I.; Ferber, F.; Gavras, H.; Brunner, H.R. and Schelling, H.L.: Effect of a new angiotensin converting enzyme inhibitor MK-421 and its lysine analogue on the components of the renin system in healthy subjects. British Journal of Clinical Pharmacology 11: 461–467 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brunner, H.R.; Gavras, H.; Waeber, B.; Kershaw, G.R.; Turini, G.A.; Vukovich, R.A.; Mckinstry, D.N. and Gavras, I.: Oral angiotensin converting enzyme inhibitor in long term treatment of hypertensive patients. Annals of Internal Medicine 90: 19–23 (1979).

    PubMed  CAS  Google Scholar 

  • Bühler, F.R.; Laragh, J.H.; Baer, L.; Vaughan, E.D. and Brunner, H.R.: Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive disease. New England Journal of Medicine 287: 1209–1214 (1972).

    Article  PubMed  Google Scholar 

  • Captopril Collaborative Study Group: Does captopril cause renal damage in hypertensive patients? Lancet 2: 988–990 (1982).

    Google Scholar 

  • Chrysant, S.G.; Brown, R.D.; Kern, D.C. and Brown, J.L.: Anti-hypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril. Clinical Pharmacology and Therapeutics 33: 741–746 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Epstein, M. and Oster, J.R.: Beta-blockers and the kidney. Mineral and Electrolyte Metabolism 8: 237–254 (1982).

    PubMed  CAS  Google Scholar 

  • Fernández, P.G.; Kim, B.K. and Galway, A.B.: An appraisal of antihypertensive efficacy and adverse reactions with two drugs regimes: Enalapril maleate as a part of triple therapy compared to conventional therapy in moderate to severe hypertension. Pharmacotherapeutica 3: 505–514 (1984).

    Google Scholar 

  • Gavras, H.; Biollaz, J.; Waeber, B.; Brunner, H.R.; Gavras, I. and Davies, R.O.: Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor MK-421. Lancet 2: 543–547 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Gifford, R.W.: Management and treatment of essential hypertension including malignant hypertension and emergencies; in Genest; Kuchel; Hamet and Cantin (Eds) Hypertension, pp. 1127–1170 (McGraw Hill, New York 1983).

    Google Scholar 

  • Groel, J.T.; Tadros, S.S.; Dreslinski, G.R. and Jenkins, A.C.: Long-term antihypertensive therapy with captopril. Hypertension 5 (Suppl. 3): 145–151 (1983).

    Google Scholar 

  • Gross, D.M.; Sweet, C.S.; Ulm, E.H.; Backlund, E.P.; Morris, A.A.; Weitz, D.; Bohn, D.L.; Wenger, H.C.; Vassill, T.C. and Stone, CA.: Antihypertensive effect of N-S[-l-carboxy-3 phenyl propyl]-L-Ala-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Journal of Pharmacology and Experimental Therapeutics 216: 552–557 (1981).

    PubMed  CAS  Google Scholar 

  • Guyton, A.C.; Coleman, T.G.; Cowley, A.W.; Scheel, K.W.; Manning, R.D. and Normal, R.A.: Arterial pressure regulation. American Journal of Medicine 52: 584–594 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Haber, E.; Koerner, T.; Page, L.B.; Kliman, B. and Puronde A.: Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. Journal of Clinical Endocrinology and Metabolism 29: 1349–1355 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Hansson, L.; Zweifler, A.J.; Julius, S. and Hungor, S.N.: Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Medica Scandinavica 196: 27–34 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Herrera-Acosta, J.; Gabbai, F.; Franco, M.; Tapia, E.; Linfa, G.; Diaz, L. and Campos, J.: Glomerular hemodynamics in persistent renovascular hypertension in the rat. Hypertension 5 (Suppl. 5): 110–114 (1983).

    Google Scholar 

  • Herrera-Acosta, J.; Fernández, M.; Gabbai, F.; Moscoso, J.; López, G.; Romero, E. and Pena, J.C.: Renal hemodynamic response to protein loading in essential hypertension. Abstracts of the IXth International Congress of Nephrology, Los Angeles, California USA pp.210A (1984).

  • Hofbauer, K.G.; Hulthen, L.V. and Bühler, F.R.: Antagonist inhibitors of the renin angiotensin system for the treatment of hypertension; in Genest, Kuchel, Hamet and Cantin (Eds) Hypertension, pp. 1225–1238 (McGraw-Hill, New York 1983).

    Google Scholar 

  • Ito, K., Koike, H.; Miyumoto, M.; Ozaki, H.; Kishimoto, T. and Urakawa, N.: Long term effects of captopril on cellular sodium content and mechanical properties of aortic smooth muscle from spontaneously hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 219: 520–525 (1981).

    PubMed  CAS  Google Scholar 

  • Merck Sharp & Dohme Research Laboratories. Multicenter Study for evaluation of the antihypertensive effect of enalapril maleate compared with propranolol as single entities and/or hydrochlorothiazide (25 and 50mg) in patients with mild or moderate essential hypertension. Data on File (1983).

  • Navar, L.G. and Rosivall, L.: Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney International 25: 857–868 (1984).

    Article  PubMed  CAS  Google Scholar 

  • Peart, W.S.: General review of hypertension; in Genest, Kuchel, Hamet and Cantin (Eds) Hypertension, pp.3–14 (McGraw Hill, New York 1983).

    Google Scholar 

  • Stumpe, K.O.; Overlack, A.; Kolloch, R. and Schreyer, S.: Long term efficacy of angiotensin converting enzyme inhibition with captopril in mild to moderate essential hypertension. British Journal of Clinical Pharmacology 14 (Suppl. 2): S121–S126 (1982).

    Article  Google Scholar 

  • Stumpe, K.O.; Kolloch, R. and Overlack, A.: Captopril and enalapril: evaluation of therapeutic efficacy and safety. Practical Cardiology 10, No. 7(1984).

  • Tarazi, R.C. and Dustan, H.P.: Beta-adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. American Journal of Cardiology 29: 633–640(1972).

    Article  PubMed  CAS  Google Scholar 

  • Thurston, H. and Swales, J.D.: Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasode-pressor property of converting enzyme inhibitor. Circulation Research 42: 588–592(1978).

    Article  PubMed  CAS  Google Scholar 

  • Thurston, H.; Swales, J.D.; Bing, R.F.; Hurst, B.C. and Marck, E.S.: Vascular renin-like activity and blood pressure maintenance in the rat. Hypertension 1: 643–649 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Unger, T.; Ganten, D. and Lang, R.E.: Pharmacology of converting enzyme inhibitors: New aspects. Clinical and Experimental Hypertension A5: 1333–1354 (1983

    Article  CAS  Google Scholar 

  • Veteran’s Administration Cooperative Study Group on Anti-hypertensive Agents: Captopril: Evaluation of low doses, twice-daily doses and the addition of diuretic for the treatment of mild to moderate hypertension. Clinical Science 63 (Suppl. 8): S443–S445 (1982).

    Google Scholar 

  • Veteran’s Administration Cooperative Study Group on Anti-hypertensive Agents: Low dose captopril for the treatment of mild to moderate hypertension. Hypertension 5 (Suppl. 3): 131–144 (1983).

    Google Scholar 

  • Vlasses, P.H.; Rotmensch, H.H.; Swanson, B.N.; Mojaverian, P. and Ferguson, R.K.: Low dose captopril. Its uses in mild to moderate hypertension unresponsive to diuretic treatment. Archives of Internal Medicine 142: 1098–1101 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Warren, S.E.; O’Connors, D.T.; Cohen, I.M. and Mitas, J.A.: Renal hemodynamic changes during long-term antihypertensive therapy. Clinical Pharmacology and Therapeutics 29: 310–317 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Weber, M.A. and Drayer, J.I.M.: Renal effects of beta-adreno-receptor blockade. Kidney International 18: 686–699 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman, B.G.; Gomer, S.F. and Liao, J.C.: Action of angiotensin on vascular adrenergic nerve endings: Facilitation of norepinephrine release. Federation Proceedings 31: 1344–1350 (1972).

    PubMed  CAS  Google Scholar 

  • Zusman, R.M.: Renin and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney International 25: 969–983 (1984).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Instituto Nacional de Cardiologia, Ignacio Chávez, Juan Badiano 1, Del. Tlalpan, 14080, Mexico, DF, Mexico

    Jaime Herrera-Acosta & Héctor Pérez-Grovas

  2. Department of Nephrology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico

    Margarita Fernández & Jaime Arriaga

Authors
  1. Jaime Herrera-Acosta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Héctor Pérez-Grovas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margarita Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaime Arriaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrera-Acosta, J., Pérez-Grovas, H., Fernández, M. et al. Enalapril in Essential Hypertension. Drugs 30 (Suppl 1), 35–46 (1985). https://doi.org/10.2165/00003495-198500301-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198500301-00006

Keywords

Search

Navigation